Isocitrate dehydrogenase (IDH) inhibitor, Olutasidenib, Purity ≥98%

Cat. No.: X24-09-YM327

Isocitrate dehydrogenase (IDH) inhibitor, Olutasidenib, Purity ≥98%

Synonym: 1887014-12-1; Olutasidenib; FT-2102; FT 2102; FT2102; 5-[[(1S)-1-(6-Chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile; Isocitrate dehydrogenase (IDH) inhibitor

  • CAS Number: 1887014-12-1
  • Compound CID: 118955396
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Olutasidenib, soluble in DMSO and insoluble in water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting isocitrate dehydrogenase (IDH). The molecular weight of the compound is 354.79, and its molecular formula is C18H15ClN4O2.
Molecular Weight
354.79
Molecular Formula
C18H15ClN4O2
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Solubility
In vitro: DMSO: 70 mg/mL (197.29 mM); Water: insoluble; Ethanol: insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Olutasidenib can be used for its ability to inhibit the mutated IDH1 enzyme and counteract the oncogenic effects of its aberrant activity.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0